The aim of the study is to provide patients with certain kinds of cancer continued access to the same drug they have received in a previous study, if they have benefited from the use of the drug. ...

Mise à jour : Il y a 4 ans
Référence : U1111-1184-2041

The aim of the study is to provide patients with certain kinds of cancer continued access to the same drug they have received in a previous study, if they have benefited from the use of the drug. El objetivo de este estudio seguir ofreciendo a los pacientes acceso al mismo medicamento que han venido recibiendo en un estudio previo, si han tenido beneficio del uso del medicamento

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Primary Objective: To provide continued access of ixazomib and to evaluate the long-term safety profile of ixazomib. Objetivo Principal: Seguir ofreciendo acceso a ixazomib y evaluar la seguridad a largo plazo de este fármaco.


Critère d'inclusion

  • The patient population will consist of patients who have previously received and tolerated ixazomib in a Millennium-sponsored clinical study, and in the investigator’s opinion and confirmed by the Millennium medical monitor, may benefit from continued ixazomib therapy,La población del estudio estará formada por pacientes que hayan recibido ixazomib anteriormente, y lo hayan tolerado, en un estudio clínico patrocinado por Millennium y que, según la opinión del investigador y con la confirmación del monitor médico de Millennium, puedan beneficiarse de continuar con el tratamiento con ixazomib

Liens